S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.04%) $0.791
USD/RUB
(0.86%) $85.73

Realtime updates for immatics biotechnologies [IMTXW]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Jun 2024 @ 16:00

2.21% $ 2.77

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.01% compare to its pairs and should correct downwards.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States...

Stats
Today's Volume 1
Average Volume 0
Market Cap 1.16B
EPS $-0.0311 ( Q1 | 2024-05-14 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
(Sector) 42.63
(Industry) 24.32
ATR14 $0 (0.00%)
AADI -10.43%
ABCL 2.78%
ABCM 0.04%
ABEO 1.19%
ABIO 6.39%
ABOS 2.54%
ABSI 0.98%
ABUS -0.32%
ABVX 3.69%
ACAD -0.73%
ACER -17.95%
ACET -9.70%
ACGN 1.29%
ACHL 0.62%
ACHV 1.29%
ACIU 0.50%
ACLX 1.98%
ACRV 0.69%
ACST -2.67%
ACXP -2.60%
ADAG 6.66%
ADAP -0.60%
ADGI 0.87%
ADIL 1.77%
ADMA 2.10%
ADPT 4.62%
ADTX -2.84%
ADVM -1.72%
ADXN -3.06%
AEON -0.94%
AEZS -2.64%
AFMD 0.00%
AGEN 18.63%
AGIO -1.12%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 3.11%
AKRO 0.26%
AKTX 0.75%
AKUS 0.00%
ALBO 0.00%
ALDX -2.65%
ALEC 0.00%
ALGS -7.51%
ALKS -0.78%
ALLK -5.66%
ALLO -4.51%
ALLR 3.85%
ALNA 3.16%
ALNY -1.62%
ALPN 0.02%
ALPX 0.00%
ALRN -4.48%
ALT 4.15%
ALVR -7.27%
ALXN 0.00%
ALXO 3.34%
ALZN -0.65%
AMRN -1.84%
AMTI -3.13%
ANAB 1.05%
ANEB 3.80%
ANGN 0.00%
ANIX -7.14%
ANL -6.05%
ANNX 1.66%
ANPC -3.15%
APGE -1.50%
APGN 8.48%
APGNW 30.65%
APLM 1.30%
APLS -7.61%
APLT 1.52%
APM -5.26%
APOP 0.38%
APRE -0.49%
APTO 1.20%
APTX 3.17%
APVO -40.57%
ARAV -13.39%
ARCT -0.41%
ARDS -17.87%
ARDX 14.00%
ARGX -3.35%
ARNA 0.00%
ARPO -0.90%
ARQT -1.27%
ARTL 3.08%
ARTLW 0.00%
ARVN 2.98%
ARWR 1.17%
ASLN 4.90%
ASMB -6.03%
ASND 0.72%
ATAI 0.76%
ATHA 0.38%
ATHE 0.56%
ATHX -33.50%
ATNF 9.27%
ATOS 4.39%
ATRA 2.91%
ATXI -2.23%
ATXS -1.30%
AUPH 1.60%
AURA 3.85%
AUTL 4.50%
AVBP 6.61%
AVEO 0.00%
AVIR -2.07%
AVRO -1.41%
AVTE -0.60%
AVTX -5.53%
AVXL -1.63%
AXLA 0.00%
AXSM 0.51%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.52%
BCAB -6.80%
BCDA -0.34%
BCDAW 0.00%
BCEL 0.00%
BCLI -6.08%
BCRX 1.15%
BCTX 9.62%
BCTXW 1.47%
BCYC -0.15%
BDRX 2.98%
BDTX -0.85%
BEAM -2.29%
BFRA -2.91%
BGNE -2.00%
BIOR 2.37%
BIVI -10.22%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -1.37%
BLTE -1.76%
BLU 0.03%
BLUE 3.74%
BMEA -0.66%
BMRN -1.40%
BNOX 3.51%
BNTC -0.71%
BNTX -0.02%
BOLD -14.76%
BOLT 0.32%
BPMC -0.68%
BPTH 2.56%
BPTS -13.47%
BRNS 1.45%
BRTX 10.93%
BTAI 0.79%
BTTX 30.91%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -2.44%
CABA 1.91%
CADL 5.26%
CALA 0.00%
CALC 25.71%
CALT 0.72%
CAPR 2.80%
CARA -15.27%
CARM 18.75%
CASI 12.24%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 3.79%
CCCC 0.00%
CCXI 0.00%
CDAK 0.00%
CDIO 0.37%
CDIOW 21.56%
CDMO 1.85%
CDMOP 0.04%
CDT 3.92%
CDTTW -12.92%
CDTX 6.70%
CDXC 3.02%
CDXS 2.99%
CELC 0.68%
CELU 11.79%
CELUW 0.00%
CERC -1.68%
CERE 0.96%
CERO -1.77%
CEROW 43.57%
CFRX -27.95%
CGEM 2.05%
CGEN -4.55%
CGON 4.36%
CGTX -0.60%
CHMA -6.00%
CHRS 1.76%
CINC 0.00%
CING -45.21%
CINGW 4.85%
CKPT 4.37%
CLBS -16.75%
CLDX -1.80%
CLGN -0.60%
CLLS 0.54%
CLNN -3.47%
CLNNW 3.32%
CLRB 7.30%
CLSD 1.56%
CLSN -0.68%
CLVS 0.00%
CMMB -4.26%
CMND 25.37%
CMPI 0.00%
CMPX -16.67%
CMRA 0.00%
CMRAW 33.33%
CMRX -1.47%
CNCE 0.00%
CNSP -4.82%
CNST 0.00%
CNTA 0.56%
CNTB 18.75%
CNTX -0.25%
COCP -8.63%
COEPW 0.00%
COGT -0.12%
CORT 1.34%
COYA -0.49%
CPRX 2.99%
CRBP 3.12%
CRBU -2.38%
CRDF -4.72%
CRGX 4.99%
CRIS -7.38%
CRNX 3.04%
CRSP -2.47%
CRTX 2.63%
CRVO -0.29%
CRVS -2.67%
CSBR 0.39%
CTCX 9.02%
CTIC 0.06%
CTMX -3.17%
CTNM -6.08%
CTXR -8.54%
CUE -11.43%
CVAC 1.19%
CVKD 1.82%
CWBR 0.00%
CYAD -12.96%
CYCC -4.71%
CYCCP -11.68%
CYCN 5.99%
CYT -2.27%
CYTK 0.74%
CYTO 0.00%
DARE -8.79%
DAWN -0.36%
DBTX -0.81%
DBVT -5.53%
DFFN 10.28%
DICE 0.06%
DMAC -3.28%
DNLI 1.09%
DNTH 3.85%
DOMH -1.58%
DRMA 4.37%
DRMAW 7.69%
DRNA 0.00%
DRTS 23.41%
DRTSW -8.84%
DRUG 2.32%
DSGN 0.00%
DTIL 3.29%
DYAI -6.33%
EARS -1.77%
EDIT -1.48%
EDSA -2.51%
EFTR -6.42%
EFTRW 0.00%
EIGR -9.21%
ELAB -1.48%
ELDN 1.54%
ELEV 7.57%
ELOX 12.20%
ELTX -40.35%
ELVN -0.34%
ELYM -5.58%
ENGN 5.13%
ENGNW -0.83%
ENLV -4.70%
ENOB 1.79%
ENSC -2.78%
ENTA 2.37%
ENTO 2.51%
ENTX -5.64%
ENVB 0.71%
EPIX 1.54%
EPRX 0.78%
EPZM 0.00%
EQ 3.77%
EQRX -2.09%
EQRXW 0.00%
ERAS 2.16%
ERNA 5.17%
ERYP 1.30%
ESLA 12.90%
ESLAW 0.00%
ETNB 6.23%
ETON -0.90%
ETTX 0.00%
EVAX 1.05%
EVGN -5.74%
EVLO 0.00%
EWTX 2.91%
EXAI -2.30%
EXEL -0.27%
EYEG -0.50%
EYEN -14.16%
EYPT -0.57%
FATE 0.46%
FBIO 1.79%
FBIOP 1.02%
FBLG 7.08%
FBRX -2.01%
FDMT 0.29%
FENC -0.65%
FGEN -13.37%
FHTX 0.17%
FIXX 0.77%
FMTX 0.00%
FNCH 13.22%
FOLD 0.10%
FREQ 4.76%
FRLN 0.15%
FRTX 5.56%
FSTX 0.00%
FTRE 2.01%
FULC -1.27%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 2.73%
GANX 2.40%
GBIO -1.05%
GBT 0.01%
GDTC 5.05%
GERN -4.50%
GHRS -2.75%
GLMD 2.46%
GLPG -1.43%
GLSI 2.25%
GLTO -5.16%
GLUE 10.65%
GLYC -11.22%
GMAB -1.76%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -6.48%
GNLX -11.36%
GNPX -3.33%
GNTA -0.32%
GOSS -5.38%
GOVX -10.28%
GOVXW -20.59%
GPCR 0.33%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -12.42%
GRTX 1.33%
GTHX 1.33%
GUTS -3.61%
GXGXW 41.67%
GYRE 20.63%
HALO 1.41%
HARP 0.09%
HCWB 1.06%
HEPA -5.55%
HGEN -84.62%
HILS 5.66%
HLVX 8.15%
HOOK -8.97%
HOTH -0.79%
HOWL -2.79%
HRMY -4.16%
HRTX 2.64%
HSTO 0.00%
HUMA 2.13%
HUMAW -1.42%
IBRX -3.36%
ICCC 11.24%
ICPT 0.21%
ICU 10.16%
ICUCW 12.50%
ICVX -0.91%
IDRA -23.04%
IDYA 2.15%
IFRX 4.19%
IGMS 3.93%
IKNA -5.71%
IKT -12.32%
IMAB -1.18%
IMCR 0.33%
IMGN 0.02%
IMGO 0.00%
IMMP 7.49%
IMMX -7.04%
IMNM 1.09%
IMNN 0.87%
IMPL -27.27%
IMRA 15.96%
IMRN -3.97%
IMRX -10.49%
IMTX -1.44%
IMTXW 2.21%
IMUX 8.82%
IMV 0.00%
IMVT 1.54%
INAB -5.87%
INBX 0.78%
INCY -1.19%
INDP -7.02%
INFI -52.38%
INKT 2.06%
INM 0.19%
INMB 1.50%
INO 4.12%
INSM 0.07%
INTS 0.20%
INVA 1.23%
INZY -1.33%
IOBT -0.85%
IONS 0.91%
IOVA 0.12%
IPA 1.23%
IPHA -1.52%
IPSC 0.79%
IRON 1.62%
ISEE 0.38%
ITOS -4.26%
ITRM -4.58%
IVA -0.33%
IVVD -8.33%
JAGX -1.11%
JANX 3.84%
JAZZ -0.35%
JNCE 0.00%
JSPR 3.13%
JSPRW 5.15%
JUNS 0.00%
JUNSW 0.00%
KA -5.43%
KALV -2.24%
KDNY 0.22%
KMPH -0.34%
KNSA 0.43%
KNTE -0.38%
KOD -3.29%
KPRX 1.20%
KPTI -10.84%
KRBP 6.83%
KRON 3.33%
KROS 1.40%
KRRO 1.20%
KRTX 0.03%
KRYS 0.42%
KTRA -3.60%
KTTA 1.62%
KTTAW 0.92%
KURA 0.44%
KYMR -1.22%
KYTX 1.90%
KZIA 2.65%
KZR -5.41%
LABP 0.57%
LBPH 20.19%
LBPS 0.00%
LBPSW 14.81%
LEGN -0.83%
LENZ -2.92%
LEXX 5.70%
LEXXW -5.15%
LGND 2.34%
LGNDV 0.00%
LGVN -4.17%
LIAN -8.28%
LIFE 2.70%
LIPO -3.43%
LIXT -2.47%
LIXTW -3.71%
LJPC -0.32%
LMNL 0.12%
LOGC -2.06%
LPCN 6.32%
LPTX 10.73%
LQDA -3.07%
LRMR -1.36%
LSTA -0.57%
LTRN 2.86%
LUMO 2.20%
LVTX -3.74%
LXEO 7.94%
LXRX -3.45%
LYEL 5.07%
LYRA 5.93%
MACK 0.10%
MBIO 1.59%
MBRX -3.83%
MCRB -7.80%
MDGL -1.93%
MDNA -13.16%
MDWD 4.30%
MDXG 2.51%
MEIP -1.36%
MESO -0.58%
MGNX 3.16%
MGTA -7.74%
MGTX -0.47%
MGX 8.22%
MIRM 3.26%
MIRO 0.59%
MIST 2.33%
MITO 0.00%
MLEC 1.85%
MLECW -28.57%
MLND -5.36%
MLTX 5.47%
MLYS 1.74%
MNKD -1.32%
MNMD -0.55%
MNOV 0.00%
MNPR -1.67%
MOLN 4.33%
MOR 0.17%
MORF 0.18%
MREO 3.45%
MRKR 12.42%
MRNA -2.01%
MRNS -4.88%
MRSN 0.75%
MRTX -0.17%
MRUS -1.71%
MRVI 1.13%
MTCR -1.29%
MTEM 3.60%
MTP -18.50%
MURA 2.28%
MYMD -1.08%
NAMS -1.69%
NAMSW -3.11%
NAUT 2.63%
NBRV 0.71%
NBSE -1.56%
NBTX -10.71%
NCNA -4.49%
NERV 4.59%
NEXI 0.00%
NGM -1.28%
NGNE 4.51%
NKGN 2.42%
NKGNW -12.00%
NKTR 8.77%
NKTX 0.85%
NLSP -9.63%
NLSPW 7.48%
NMRA 6.85%
NMTR -42.97%
NOVN -24.84%
NRBO 0.83%
NRIX 0.63%
NRSN 9.80%
NRSNW 21.18%
NRXP -6.87%
NRXPW -16.53%
NRXS 4.51%
NTBL -6.32%
NTEC -12.45%
NTHI 0.00%
NTLA -3.49%
NTRBW 74.65%
NUVL -1.44%
NVAX -1.33%
NVCT 0.96%
NVIV -34.28%
NXTC -3.05%
NYMX -0.05%
OABI -0.53%
OABIW 6.37%
OBIO 2.77%
OBSV 0.00%
OCEA -11.59%
OCGN 8.39%
OCS 1.44%
OCUL 1.18%
OCUP 0.66%
ODT -4.27%
OKYO 0.85%
OLMA -3.48%
OMER 2.78%
OMGA -7.59%
ONCO -18.40%
ONCR -3.08%
ONCS 31.87%
ONCT -1.17%
ONCY -1.98%
ONTX -0.47%
ONVO -0.41%
OPNT 0.00%
OPT 3.21%
ORGS -5.36%
ORIC 2.32%
ORMP -4.10%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.73%
OVID 5.89%
OYST 0.00%
PALI -1.53%
PASG -14.04%
PBLA 11.11%
PBM -8.81%
PBYI 0.93%
PCSA 8.21%
PCVX -4.14%
PDSB -2.66%
PEPG -3.04%
PGEN 4.64%
PHAR 3.47%
PHAS 0.00%
PHAT -0.96%
PHIO 1.75%
PHIOW 36.47%
PHVS 4.39%
PHXM -5.20%
PIRS 5.83%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 0.84%
PLUR 7.04%
PMN -1.96%
PMVP -2.41%
PNT 0.16%
PPBT -6.42%
PRAX 4.02%
PRDS 0.93%
PRLD 3.25%
PROG -3.47%
PROK 1.65%
PRQR 0.61%
PRTA 0.54%
PRTC 4.56%
PRTG -6.11%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -1.34%
PSTX 7.35%
PTCT -11.77%
PTE -0.82%
PTGX 8.69%
PTIXW -47.77%
PULM 0.52%
PXMD -9.45%
PYPD 3.12%
PYXS 3.12%
QLGN -3.31%
QNCX 4.87%
QNRX -2.85%
QSI 11.70%
QSIAW 4.08%
QTTB 17.70%
QURE -1.32%
RAIN -1.63%
RANI -3.55%
RAPT 5.54%
RARE -0.77%
RCKT 0.47%
REGN 0.02%
RENB 16.67%
REPL 5.63%
RETA 0.02%
REUN -0.89%
REVB 2.69%
REVBU 3.46%
REVBW 19.05%
RGLS -11.85%
RGNX 0.60%
RIGL -13.75%
RLAY 3.49%
RLMD 0.33%
RLYB -9.46%
RNA 0.76%
RNAC -5.29%
RNAZ -0.50%
RNXT -2.59%
ROIV 0.00%
ROIVW 4.56%
RPHM -6.21%
RPRX -1.12%
RPTX -2.37%
RUBY 2.70%
RVLP -32.05%
RVMD 0.73%
RVMDW 45.86%
RVNC -0.39%
RVPH 0.00%
RVPHW 1.89%
RXDX 0.09%
RXRX -0.99%
RYTM 2.32%
RYZB 0.02%
RZLT 7.23%
SABS 6.16%
SABSW 35.43%
SAGE 1.59%
SANA 1.11%
SAVA -34.83%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -2.80%
SCPH -0.46%
SCPS 0.00%
SEEL -2.10%
SEER -4.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -10.11%
SGMT -16.79%
SGTX -2.56%
SIOX 22.63%
SLDB -1.22%
SLGL 3.37%
SLN 0.00%
SLNO -2.28%
SLRX -2.86%
SLS 4.39%
SMMT -0.89%
SNDX 1.03%
SNGX -7.19%
SNPX 0.99%
SONN -1.41%
SPPI -0.49%
SPRB -2.72%
SPRC -5.99%
SPRO -2.99%
SRNE 5.26%
SRPT 0.03%
SRRA 0.00%
SRRK -0.36%
SRZN 10.16%
STAB 0.00%
STOK 1.50%
STRO 0.34%
STSA 0.00%
STTK 2.93%
SURF -0.93%
SVRA 5.77%
SWTX 0.37%
SYBX -1.96%
SYRS -9.95%
TALS -0.73%
TARA -4.15%
TARS 7.99%
TBPH 1.80%
TCBP -1.31%
TCDA 0.00%
TCON -1.38%
TCRR 0.00%
TCRT -2.92%
TCRX -6.25%
TECH -0.24%
TENX 1.17%
TERN -4.22%
TFFP 3.11%
TGTX -0.89%
THRX 0.12%
TIL -1.06%
TLC 0.00%
TLSA 4.43%
TNGX 0.47%
TNXP 1.07%
TNYA 5.44%
TPST 0.92%
TRDA 0.56%
TRVI 1.36%
TRVN 1.40%
TSHA 3.46%
TSVT 2.39%
TTNP 0.91%
TVTX -0.72%
TYRA 3.50%
UBX -2.17%
UNCY 23.70%
URGN -1.12%
UTHR 0.51%
VACC 11.36%
VALN -5.14%
VAXX -0.24%
VBIV 1.54%
VBLT -8.77%
VCEL -2.20%
VCNX 2.69%
VCYT -1.46%
VERA 4.39%
VERU 5.16%
VERV 2.52%
VIGL -10.71%
VINC 9.46%
VIR 0.34%
VIRI -8.20%
VIRX -5.93%
VKTX 4.41%
VLON -13.04%
VNDA -2.75%
VOR -12.28%
VRCA 0.97%
VRDN 1.80%
VRNA -6.35%
VRPX -0.52%
VRTX -0.80%
VSTM 2.76%
VTGN 0.00%
VTVT -0.34%
VTYX -3.35%
VXRT 0.20%
VYGR 0.64%
VYNE 0.00%
VYNT 7.78%
WINT -3.60%
WVE 0.00%
XBIO 1.50%
XBIT 11.50%
XCUR 5.89%
XENE 4.22%
XERS -0.44%
XFOR -13.45%
XLO 0.80%
XLRN 0.00%
XNCR -1.41%
XOMA 3.45%
XOMAO 0.24%
XOMAP 0.08%
XRTX 0.00%
YMAB -2.03%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -1.08%
ZNTL -2.62%
ZSAN 0.00%
Correlation (AI algo v.1.1b): Overvalued: -0.01% $2.77 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

immatics biotechnologies Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

immatics biotechnologies Financials

Annual 2023
Revenue: $54.00M
Gross Profit: $-64.67M (-119.76 %)
EPS: $-1.200
FY 2023
Revenue: $54.00M
Gross Profit: $-64.67M (-119.76 %)
EPS: $-1.200
FY 2022
Revenue: $172.83M
Gross Profit: $66.05M (38.22 %)
EPS: $0.550

Financial Reports:

No articles found.

immatics biotechnologies Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

immatics biotechnologies

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.0996100902557 seconds
Number of API calls: 3
Number of DB calls: 9